OBI Pharma has received clearance from the US Food and Drug Administration (FDA) for an investigational new drug (IND) ...

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for milsaperidone (Bysanti™) for the treatment of acute ...

Atara Biotherapeutics said a clinical hold on its new drug applications for its Ebvallo tabelecleucel program to treat Epstein-Barr virus by has been lifted by the Food and Drug Administration. The ...

Plainsboro, New Jersey Monday, May 5, 2025, 14:00 Hrs [IST] ...

For five years, the clinical-stage pharmaceutical company has developed Enbumyst, a nasal spray intended to remove excess ...

RESEARCH TRIANGLE PARK, N.C., May 05, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today reported ...

The US Food and Drug Administration (FDA) has accepted Novo Nordisk’s new drug application (NDA) submission for the 25 mg ...

Robert F. Kennedy Jr. is being sued by California, New York, Washington, Arizona, Colorado and other states over what they ...

This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...

Corcept Therapeutics (NASDAQ: CORT) reported first quarter earnings that beat analyst expectations, but revenue fell short of estimates, sending shares down 8.7% ...

Despite the blue states' lawsuit, RFK Jr. defends his restructuring of HHS from 28 divisions to 15, saying it will make it ...

Achieved $20.0 million in Revuforj net revenue in the first quarter of 2025, the first full quarter of the U.S. launch. Revuforj was launched in the U.S. in late November 2024 for the treatment of ...